"Adjuvants, Pharmaceutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.
| Descriptor ID |
D000277
|
| MeSH Number(s) |
D26.650.064 D27.720.744.064
|
| Concept/Terms |
Adjuvants, Pharmaceutic- Adjuvants, Pharmaceutic
- Adjuvant, Pharmaceutical
- Adjuvants, Pharmaceutical
- Pharmaceutical Adjuvants
- Pharmaceutic Adjuvants
- Pharmaceutical Adjuvant
- Adjuvant, Pharmaceutic
- Pharmaceutic Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Adjuvants, Pharmaceutic".
Below are MeSH descriptors whose meaning is more specific than "Adjuvants, Pharmaceutic".
This graph shows the total number of publications written about "Adjuvants, Pharmaceutic" by people in this website by year, and whether "Adjuvants, Pharmaceutic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adjuvants, Pharmaceutic" by people in Profiles.
-
Tosur M, Redondo MJ, Lyons SK. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes. Curr Diab Rep. 2018 08 17; 18(10):79.
-
Clifton GT, Mittendorf EA, Peoples GE. Adjuvant HER2/neu peptide cancer vaccines in breast cancer. Immunotherapy. 2015; 7(11):1159-68.
-
Graham DY. Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants. Helicobacter. 2015 Oct; 20(5):321-5.
-
Nagaraja AS, Sadaoui NC, Lutgendorf SK, Ramondetta LM, Sood AK. ß-blockers: a new role in cancer chemotherapy? Expert Opin Investig Drugs. 2013 Nov; 22(11):1359-63.
-
Simon GR, Manegold C, Barker SS, Treat JA, Visseren-Grul C, Obasaju C. Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancer. Clin Lung Cancer. 2013 Nov; 14(6):601-8.
-
Khan MI, Walsh D, Brito-Dellan N. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care. 2011 Aug; 28(5):378-83.
-
Ambalavanar R, Yallampalli C, Yallampalli U, Dessem D. Injection of adjuvant but not acidic saline into craniofacial muscle evokes nociceptive behaviors and neuropeptide expression. Neuroscience. 2007 Nov 09; 149(3):650-9.
-
Couch RB. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N Engl J Med. 2004 Feb 26; 350(9):860-1.
-
Nasongkla N, Wiedmann AF, Bruening A, Beman M, Ray D, Bornmann WG, Boothman DA, Gao J. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes. Pharm Res. 2003 Oct; 20(10):1626-33.
-
Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001 Jul 04; 93(13):979-89.